Reducing Non-Alcoholic Steatohepatitis

NCT06519448 · clinicaltrials.gov ↗

NA

Phase

ENROLLING_BY_INVITATION

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Non-alcoholic Steatohepatitis
Liver Diseases
Diabetes Mellitus, Type 2
Fibrosis, Liver

Interventions

DRUG: Empagliflozin 10 miligrams (mg)

Sponsor

Military University Hospital, Prague